SCI Pharmtech Inc
TWSE:4119
SCI Pharmtech Inc
Cash Interest Paid
SCI Pharmtech Inc
Cash Interest Paid Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash Interest Paid | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
S
|
SCI Pharmtech Inc
TWSE:4119
|
Cash Interest Paid
NT$5.5m
|
CAGR 3-Years
413%
|
CAGR 5-Years
154%
|
CAGR 10-Years
N/A
|
|
|
Y
|
YungShin Global Holding Corp
TWSE:3705
|
Cash Interest Paid
NT$31.3m
|
CAGR 3-Years
1%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
4%
|
|
|
Formosa Laboratories Inc
TWSE:4746
|
Cash Interest Paid
NT$40.5m
|
CAGR 3-Years
27%
|
CAGR 5-Years
1%
|
CAGR 10-Years
9%
|
|
|
ScinoPharm Taiwan Ltd
TWSE:1789
|
Cash Interest Paid
NT$8.1m
|
CAGR 3-Years
7%
|
CAGR 5-Years
-34%
|
CAGR 10-Years
7%
|
|
|
Lotus Pharmaceutical Co Ltd
TWSE:1795
|
Cash Interest Paid
NT$495.1m
|
CAGR 3-Years
30%
|
CAGR 5-Years
12%
|
CAGR 10-Years
36%
|
|
|
Standard Chem & Pharm Co Ltd
TWSE:1720
|
Cash Interest Paid
NT$15.5m
|
CAGR 3-Years
29%
|
CAGR 5-Years
8%
|
CAGR 10-Years
9%
|
|
SCI Pharmtech Inc
Glance View
SCI Pharmtech Corp. is engaged in the biotechnology and medical care industry. The company is headquartered in Taoyuan, Taoyuan. The company went IPO on 2002-08-12. The firm's main products include APIs, API intermediates and special and precision chemicals. The firm distributes its products in domestic market and to overseas markets, including Europe, the Americas, the rest areas of Asia and others
See Also
What is SCI Pharmtech Inc's Cash Interest Paid?
Cash Interest Paid
5.5m
TWD
Based on the financial report for Dec 31, 2024, SCI Pharmtech Inc's Cash Interest Paid amounts to 5.5m TWD.
What is SCI Pharmtech Inc's Cash Interest Paid growth rate?
Cash Interest Paid CAGR 5Y
154%
Over the last year, the Cash Interest Paid growth was -12%. The average annual Cash Interest Paid growth rates for SCI Pharmtech Inc have been 413% over the past three years , 154% over the past five years .
You don't have any saved screeners yet